Two former FDA leaders look at Commissioner Marty Makary’s early stumbles — and lay out a list of priorities to protect both ...

A vow by the agency’s new commissioner, Marty Makary, to support innovation might ease fears stoked by Health and Human ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

One of the FDA’s recently departed top officials is weighing in on the wide-ranging staff cuts at the agency and how they ...

At its first meeting under the new administration, the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted on recommendations for several ...

In the wake of unprecedented workforce cuts at the FDA, former Commissioner Scott Gottlieb and an unnamed former CBER ...

He is the head of HHS, and yet he continues to spout untested, unproven therapies and has only given a very lukewarm recommendation for the measles vaccine to stop the ongoing measles outbreak that is ...

The biotech industry is facing a major hurdle as widespread layoffs at the U.S. Food and Drug Administration (FDA) disrupt the drug development process. Biotech firms—particularly smaller ones—are ...

The CDC's Advisory Committee on Immunization Practices (ACIP) voted 14-0, with one abstention, on Wednesday to recommend that ...

"The FDA anticipates that there will be an adequate and diverse supply of approved trivalent seasonal influenza vaccines" for the upcoming season, said the agency in its statement. President ...